Therapeutic prospects of nectin-4 in cancer: applications and value
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Nectin-4, a protein overexpressed in cancers, is a promising target for new cancer therapies. Research is ongoing to understand its role in tumorigenesis and develop effective treatments like enfortumab vedotin.
Area Of Science
- Oncology
- Molecular Biology
- Immunotherapy
Background
- Nectin-4 is a cell adhesion molecule with significantly elevated expression in various malignant tumors compared to healthy tissues.
- Overexpression of Nectin-4 is linked to the occurrence and progression of cancers such as breast, urothelial, and lung cancer.
Purpose Of The Study
- To review the diagnostic potential, prognostic significance, and molecular role of Nectin-4 in tumors.
- To focus on Nectin-4-targeted therapies, including clinical trials and new drug development for malignant tumors.
Main Methods
- Literature review of studies on Nectin-4 expression in tumors.
- Analysis of clinical trial data for Nectin-4-targeted therapies.
- Review of molecular mechanisms underlying Nectin-4's role in tumorigenesis.
Main Results
- Nectin-4 is a validated therapeutic target, evidenced by the FDA approval of enfortumab vedotin for urothelial carcinoma.
- Numerous Nectin-4-targeting drugs are in clinical trials for various cancers, indicating its therapeutic potential.
- The precise mechanisms of Nectin-4 in tumorigenesis and progression remain under investigation.
Conclusions
- Nectin-4 holds significant promise as a diagnostic and prognostic biomarker and a therapeutic target in oncology.
- Further research into Nectin-4's molecular functions and overcoming challenges like drug resistance is crucial for advancing targeted cancer therapies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.